Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Sethi

Showing results (91-100 of 206) with videos related to

Pageof 21
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 10, 2002
Inflammatory markers in bacterial exacerbations of COPDTimothy F Murphy, Sanjay Sethi, Susan L Hill, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2004
Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary diseaseTimothy F Murphy, Aimee L Brauer, Andrew T Schiffmacher, et al.
BMC Infectious Diseases|November 17, 2009
Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary diseaseGanapathi I Parameswaran, Catherine T Wrona, Timothy F Murphy, et al.
Infection and Immunity|September 24, 2005
Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalisDiana G Adlowitz, Sanjay Sethi, Paul Cullen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 18, 2020
Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison StudiesThomas P Lodise, Jingyi Li, Hitesh N Gandhi, et al.
American Journal of Respiratory and Critical Care Medicine|April 5, 2005
Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune responseTimothy F Murphy, Aimee L Brauer, Brydon J B Grant, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 1, 2025
Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μLSanjay Sethi, Brendan Clark, Erin K Buysman, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2007
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary diseaseSanjay Sethi, Catherine Wrona, Karen Eschberger, et al.
Infection and Immunity|May 23, 2006
Differential genome contents of nontypeable Haemophilus influenzae strains from adults with chronic obstructive pulmonary diseaseMatthew M Fernaays, Alan J Lesse, Sanjay Sethi, et al.
Plos One|January 25, 2019
Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionateKarin A Provost, Miyuki Smith, Anna Miller-Larsson, et al.
Pageof 21

Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
American Journal of Respiratory and Critical Care Medicine|January 10, 2002
Inflammatory markers in bacterial exacerbations of COPDTimothy F Murphy, Sanjay Sethi, Susan L Hill, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2004
Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary diseaseTimothy F Murphy, Aimee L Brauer, Andrew T Schiffmacher, et al.
BMC Infectious Diseases|November 17, 2009
Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary diseaseGanapathi I Parameswaran, Catherine T Wrona, Timothy F Murphy, et al.
Infection and Immunity|September 24, 2005
Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalisDiana G Adlowitz, Sanjay Sethi, Paul Cullen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 18, 2020
Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison StudiesThomas P Lodise, Jingyi Li, Hitesh N Gandhi, et al.
American Journal of Respiratory and Critical Care Medicine|April 5, 2005
Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune responseTimothy F Murphy, Aimee L Brauer, Brydon J B Grant, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 1, 2025
Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μLSanjay Sethi, Brendan Clark, Erin K Buysman, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2007
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary diseaseSanjay Sethi, Catherine Wrona, Karen Eschberger, et al.
Infection and Immunity|May 23, 2006
Differential genome contents of nontypeable Haemophilus influenzae strains from adults with chronic obstructive pulmonary diseaseMatthew M Fernaays, Alan J Lesse, Sanjay Sethi, et al.
Plos One|January 25, 2019
Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionateKarin A Provost, Miyuki Smith, Anna Miller-Larsson, et al.
Pageof 21